Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.1007/s10620-021-06902-w
|View full text |Cite
|
Sign up to set email alerts
|

Early-Onset Colorectal Cancer Is Associated with a Lower Risk of Metachronous Advanced Neoplasia than Traditional-Onset Colorectal Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(13 citation statements)
references
References 20 publications
0
11
0
Order By: Relevance
“…In a retrospective case-control study (107 eoCRC and 139 loCRC), patients received similar recommendations for endoscopic surveillance after curative surgery, but patients with eoCRC were more adherent to recommendations (71% versus 55%; P ¼ .01). 102 The risk of metachronous advanced adenoma or CRC after curative resection was lower for patients with eoCRC (adjusted HR, 0.44; 95% CI, 0.22-0.88). 102 The 5-year event rate for metachronous advanced adenoma and CRC was lower for patients with eoCRC (5.8% vs 16.1%; P ¼ .07).…”
Section: Le: 3bmentioning
confidence: 92%
See 4 more Smart Citations
“…In a retrospective case-control study (107 eoCRC and 139 loCRC), patients received similar recommendations for endoscopic surveillance after curative surgery, but patients with eoCRC were more adherent to recommendations (71% versus 55%; P ¼ .01). 102 The risk of metachronous advanced adenoma or CRC after curative resection was lower for patients with eoCRC (adjusted HR, 0.44; 95% CI, 0.22-0.88). 102 The 5-year event rate for metachronous advanced adenoma and CRC was lower for patients with eoCRC (5.8% vs 16.1%; P ¼ .07).…”
Section: Le: 3bmentioning
confidence: 92%
“…102 The risk of metachronous advanced adenoma or CRC after curative resection was lower for patients with eoCRC (adjusted HR, 0.44; 95% CI, 0.22-0.88). 102 The 5-year event rate for metachronous advanced adenoma and CRC was lower for patients with eoCRC (5.8% vs 16.1%; P ¼ .07). 102…”
Section: Le: 3bmentioning
confidence: 92%
See 3 more Smart Citations